Emerging evidence indicates that the menin–MLL complex is upregulated in PCa, plays a role in AR signaling in AR-positive tumors, and can be targeted with small molecule inhibitors to reduce xenograft tumor growth [40]. Here, KMT2A is linked to neoplasm.